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Supplementary figure 1: Morphology of deposited MWCNTs upon single and repeated 
exposures. SEM images of aerosolized MWCNTs following (a) single (d1) and (b) 5 repeated 
exposures (w1).  
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Supplementary figure 2: CM-CSF activity of asthmatic and nonasthmatic control 
cultures. Quantification of GM-CSF release in healthy and asthmatic negative control 
tissues upon w1. § Shows significant response (p < 0.05) of asthma cultures when 
compared to healthy cultures.  Data are presented as the mean ± standard error of the 
mean (SEM). 
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Supplementary Figure 3: Morphological assessment of healthy and asthma cultures 
after subchronic MWCNT exposure. Light microscopy images of healthy cultures at w1 
(a) and w3 (b). Illustrated images represent asthma cells at the end of w1 (d) and w3 (e). 
White arrows indicate MWCNTs accumulated on the cells surface (scale bars: 100μm). 
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Supplementary figure 4: Morphology of healthy and asthmatic human bronchial epithelial cells 
after long term exposure to aerosolized MWCNTs. Illustrated LSM images represent cells 
exposed repeatedly to MWCNTS for either 1 week (a) or 3 weeks (b). Magenta color shows F-actin 
(cytoskeleton), blue color shows DNA (cell nuclei), yellow represents cilia and white the tight 
junctions (scale bars: 20 μm).  
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Supplementary figure 5: (Pro-)inflammatory response in cells exposed repeatedly to MWCNTs 
for up to 5 weeks. (a) IL-8, (b) IL-6 (c) IP-10 and (d) TGF-β release in the medium (n=4). TNF-α 
(1μg/ml) was used as positive control for IL-8 and IL-6 induction, while IFN-γ (1μg/ml) for IP-10 
and TGF-β respectively. # Represents a significant increase (p < 0.05) in healthy cultures compared 
to the negative control.* Indicates statistical significance in asthmatic cells compared to the negative 
control (p < 0.05). § Shows significant response (p < 0.05) of asthma cultures when compared to 
healthy cultures upon w5.  Data are presented as the mean ± standard error of the mean (SEM). 
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MWCNTs Before aerosolisation After aerosolisation 
Length (μm) 1-1027 3.4 ± 2.225 
Width (nm) 5-3027 30 ± 10.325 
Other MWCNT characteristics: 
Shape (Form) Fibrous (bundled)27, 28 
Elemental Contaminants (%wt) Fe(0.05), Mg(0.01), Ni(0.12), Co(<0.001)27, 28 
Endotoxin Content ND27, 28 
Supplementary table 1: Physicochemical characteristics of MWCNTs. Summary of key 
physicochemical MWCNTs characteristics before and after aerosolisation process as previously reported 
by 25,27,28. 
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  Genes   Direction  Primer Sequence 
GADPH   forward AAC AGC CTC AAG ATC ATC AGC  
  reverse GGA TGA TGT TCT GGA GAG CC  
 HMOX-1   forward TTC TCC GAT GGG TCC TTA CAC T 
  reverse GGC ATA AAG CCC TAC AGC AAC T  
 SOD-2   forward CTG CTG GGG ATT GAT GTG TGG 
  reverse TGC AAG CCA TGT ATC TTT CAG T 
 IL-8   forward CTG GCC GTG GCT CTC TTG   
  reverse CCT TGG CAA AAC TGC ACC TT  
 IL-6   forward CCA GGA GCC CAG CTA TGA AC 
  reverse CCC AGG GAG AAG GCA ACT G 
 IP-10   forward CCA TTC TGA TTT GCT GCC TTA TC 
  reverse GCA GGT ACA GCG TAC AGT TCT 
 TGF-β   forward CCC TAC ATT TGG AGC CTG GAC 
ACG 
  reverse CGG GTT ATG CTG GTT GTA CAG 
GGC  
Supplementary table 2: List of analysed genes and primer sequences used for real-time PCR. 
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MWCNTs   
Sub-chronic  
effects 
w1 w3 w5 
Healthy  Asthma Healthy  Asthma Healthy  Asthma 
MCC N.T N.T 
 
N.T 
 
N.T 
 
22.7 
±3.9 
26.7 
±3.2 
CBF N.T 
 
N.T 
 
N.T 
 
N.T 
 
9.37 
±0.05 
9.86 
±0.13 
HMOX-1 
(expression) 
3.95 
±3.0 
18.1 
±10.9  
5.3 
±4 
6.9 
±4 
6.57 
±2.9 
22.6 
±10.8 
SOD-2 
(expression) 
1.18 
±0.13 
4.95 
±2.8  
3.73 
±2.2 
10.55 
±8.4  
79.2 
±45.1 
104.7 
±74.6 
IL-8  
(expression) 
19.6 
±11.6  
8.8 
±3.8 
9.48 
±6.6  
10.84 
±10.5 
9.2 
±1.99 
26.4 
±7.9 
(secretion) 19360 
±7306 
11465 
±2923 
23938 
±4310 
13582 
±5181 
18792 
±6819 
44637 
±22882 
IL-6  
(expression) 
7.49 
±3.4  
6.1 
±2.6  
41.4 
±4.5  
2.4 
±1.1 
120.9 
±62.3 
196.8 
±118.2 
(secretion) 812 
±662.1 
151.4 
±27.9 
931.0 
±483.6 
259.5 
±75.5 
363.75 
±53.5 
914.4 
±514.5 
IP-10  
(expression) 
5.6 
±3.7  
0.17 
±0.1 
2.3 
±0.6 
13.7 
±8.6  
92.9 
±34.6  
29.8 
±12.4 
(secretion) 145.8 
±23.7 
243.6 
±79.2 
164.28 
±77.84 
144.79 
±35.16 
156.1 
±80.6 
116.1 
±39.8 
TGF-β 
(expression) 
5.9 
±4.5  
5.2 
±2.8  
5.2 
±4 
3.1 
±1.6  
84.7 
±69.3 
144.8 
±94.1 
(secretion) 292.9 
±9.7 
291.2 
±11.9 
301.02 
±13.63 
304.3 
±18.79 
316.46 
±15.29 
341.02 
±37.55 
Supplementary table 3: Summary of the measured biological response induced by long-term MWCNT 
exposure in bronchial epithelial cells in vitro. Values are presented as the mean ± SEM. Red values 
represent statistical significant increase. Orange values show notable increase, while green values a weak 
increase. Black values indicate no change compared to control. N.T: Not tested.  
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